Targeting cyclin-dependent kinases in sarcoma treatment: Current perspectives and future directions. [PDF]
Front Oncol, 2023 Merlini A +7 more
europepmc +1 more source
Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders. [PDF]
Front Mol Neurosci, 2022 Tian Z, Feng B, Wang XQ, Tian J.
europepmc +1 more source
Inhibition of Cyclin-Dependent Kinases 8/19 Restricts Bacterial and Virus-Induced Inflammatory Responses in Monocytes. [PDF]
Viruses, 2023 Kokinos EK +11 more
europepmc +1 more source
Design, Synthesis, Antitumour Evaluation, and In Silico Studies of Pyrazolo-[1,5-c]quinazolinone Derivatives Targeting Potential Cyclin-Dependent Kinases. [PDF]
Molecules, 2023 Zheng D +10 more
europepmc +1 more source
Sirtuin 6 is required for the integrated stress response and resistance to inhibition of transcriptional cyclin-dependent kinases. [PDF]
Sci Transl Med, 2023 Kartha N +19 more
europepmc +1 more source
Multi-omics investigation reveals functional specialization of transcriptional cyclin dependent kinases in cancer biology. [PDF]
Sci Rep, 2022 Donovan MG, Galbraith MD, Espinosa JM.
europepmc +1 more source
Risk of Cardiovascular Events with Cyclin-Dependent Kinases 4 and 6 (CDK 4/6) Inhibitors among Patients with Advanced Breast Cancer: A Systematic Review and Network Meta-Analysis. [PDF]
Rev Cardiovasc Med, 2023 Liu YS, Dong K, Park C.
europepmc +1 more source
Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer. [PDF]
Oncogene, 2022 Constantin TA +3 more
europepmc +1 more source
Comprehensive Analysis of Role of Cyclin-Dependent Kinases Family Members in Colorectal Cancer. [PDF]
Front Oncol, 2022 Guan L, Tang Y, Li G, Qin Z, Li S.
europepmc +1 more source
When cyclin-dependent kinases meet viral infections, including SARS-CoV-2. [PDF]
J Med Virol, 2022 Yan Y, Tang YD, Zheng C.
europepmc +1 more source